These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37910593)

  • 41. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.
    Gearhart M; Martin J; Rudich S; Thomas M; Wetzel D; Solomkin J; Hanaway MJ; Aranda-Michel J; Weber F; Trumball L; Bass M; Zavala E; Steve Woodle E; Buell JF
    Clin Transplant; 2005 Dec; 19(6):711-6. PubMed ID: 16313314
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.
    Jung E; Byun S; Lee H; Moon SY; Lee H
    Am J Infect Control; 2014 Oct; 42(10):1062-6. PubMed ID: 25278394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The clinical impact of vancomycin-resistant Enterococcus colonization and bloodstream infection in patients undergoing autologous transplantation.
    Ford CD; Lopansri BK; Gazdik MA; Snow GL; Webb BJ; Konopa KL; Petersen FB
    Transpl Infect Dis; 2015 Oct; 17(5):688-94. PubMed ID: 26256692
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Assessing the intestinal carriage rates of vancomycin-resistant enterococci (VRE) at a tertiary care hospital in Hungary.
    Franyó D; Kocsi B; Bukta EE; Szabó J; Dombrádi Z
    Folia Microbiol (Praha); 2020 Jun; 65(3):483-490. PubMed ID: 31686360
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Daptomycin versus linezolid for the treatment of vancomycin-resistant enterococcal bacteraemia: implications of daptomycin dose.
    Chuang YC; Lin HY; Chen PY; Lin CY; Wang JT; Chang SC
    Clin Microbiol Infect; 2016 Oct; 22(10):890.e1-890.e7. PubMed ID: 27475738
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
    Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
    Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE.
    Olivier CN; Blake RK; Steed LL; Salgado CD
    Infect Control Hosp Epidemiol; 2008 May; 29(5):404-9. PubMed ID: 18419361
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A retrospective cohort study of antibiotic exposure and vancomycin-resistant Enterococcus recolonization.
    Hughes HY; Odom RT; Michelin AV; Snitkin ES; Sinaii N; Milstone AM; Henderson DK; Palmore TN
    Infect Control Hosp Epidemiol; 2019 Apr; 40(4):414-419. PubMed ID: 30729903
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular epidemiology and risk factors for colonization by vancomycin-resistant Enterococcus in patients with hematologic malignancies.
    Almyroudis NG; Lesse AJ; Hahn T; Samonis G; Hazamy PA; Wongkittiroch K; Wang ES; McCarthy PL; Wetzler M; Segal BH
    Infect Control Hosp Epidemiol; 2011 May; 32(5):490-6. PubMed ID: 21515980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vancomycin-resistant enterococci with reduced daptomycin susceptibility in Singapore: prevalence and associated factors.
    Chow A; Win NN; Ng PY; Lee W; Win MK
    Epidemiol Infect; 2016 Sep; 144(12):2540-5. PubMed ID: 27174845
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative Epidemiology of Vancomycin-Resistant Enterococci Colonization in an Acute-Care Hospital and Its Affiliated Intermediate- and Long-Term Care Facilities in Singapore.
    Tan D; Htun HL; Koh J; Kanagasabai K; Lim JW; Hon PY; Ang B; Chow A
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30224534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The local hospital milieu and healthcare-associated vancomycin-resistant enterococcus acquisition.
    Zhou MJ; Li J; Salmasian H; Zachariah P; Yang YX; Freedberg DE
    J Hosp Infect; 2019 Jan; 101(1):69-75. PubMed ID: 30026006
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients.
    Tsiatis AC; Manes B; Calder C; Billheimer D; Wilkerson KS; Frangoul H
    Bone Marrow Transplant; 2004 May; 33(9):937-41. PubMed ID: 15034540
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 10-year trends in vancomycin-resistant enterococci among allogeneic hematopoietic cell transplant recipients.
    MacAllister TJ; Stohs E; Liu C; Bryan A; Whimbey E; Phipps A; Pergam SA
    J Infect; 2018 Jul; 77(1):38-46. PubMed ID: 29746941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections.
    Chuang YC; Chen PY; Lin CY; Chen YC; Wang JT; Chang SC
    Sci Rep; 2018 Jan; 8(1):1632. PubMed ID: 29374204
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Utilizing genomic analyses to investigate the first outbreak of vanA vancomycin-resistant Enterococcus in Australia with emergence of daptomycin non-susceptibility.
    Douglas AP; Marshall C; Baines SL; Ritchie D; Szer J; Madigan V; Chan HT; Ballard SA; Howden BP; Buising K; Slavin MA
    J Med Microbiol; 2019 Mar; 68(3):303-308. PubMed ID: 30663951
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gut Microbiota Predict
    Chanderraj R; Brown CA; Hinkle K; Falkowski N; Ranjan P; Dickson RP; Woods RJ
    mSphere; 2020 Nov; 5(6):. PubMed ID: 33208515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence and risk factors of vancomycin-resistant enterococcus colonization in burn unit patients.
    Altoparlak U; Koca O; Ozkurt Z; Akcay MN
    Burns; 2011 Feb; 37(1):49-53. PubMed ID: 20926196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital.
    Zhou Q; Moore C; Eden S; Tong A; McGeer A;
    Infect Control Hosp Epidemiol; 2008 May; 29(5):398-403. PubMed ID: 18419360
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Practical methods for effective vancomycin-resistant enterococci (VRE) surveillance: experience in a liver transplant surgical intensive care unit.
    Linfield RY; Campeau S; Injean P; Gregson A; Kaldas F; Rubin Z; Kim T; Kunz D; Chan A; Lee DJ; Humphries RM; McKinnell JA
    Infect Control Hosp Epidemiol; 2018 Oct; 39(10):1178-1182. PubMed ID: 30178725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.